Jane Wright Mitchell Insider Trading $PCVX Vaxcyte, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jane Wright Mitchell.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jane Wright Mitchell. Jane Wright Mitchell is Chief Legal Officer in ACELRX PHARMACEUTICALS INC ($ACRX) and General Counsel in Vaxcyte, Inc. ($PCVX).
Jane Wright Mitchell in Vaxcyte, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jane Wright Mitchell: General Counsel
Holdings: 4,062 shares
Latest Transaction: Apr 06 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jane Wright Mitchell in Vaxcyte, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 06 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | A | 20.93 | 93,340 | 1,953,606 | 93,340 | |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | M | 2.03 | 2,500 | 5,075 | 199,968 | |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 27.49 | 1,487 | 40,878 | 1,562 | 3 K to 1.6 K (-48.77 %) |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 27.01 | 1,013 | 27,361 | 3,049 | 4.1 K to 3 K (-24.94 %) |
| Mar 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Buy | M | 2.03 | 2,500 | 5,075 | 4,062 | 1.6 K to 4.1 K (+160.05 %) |
| Feb 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | M | 2.03 | 2,500 | 5,075 | 202,468 | |
| Feb 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 26.95 | 2,500 | 67,375 | 1,562 | 4.1 K to 1.6 K (-61.55 %) |
| Feb 17 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Buy | M | 2.03 | 2,500 | 5,075 | 4,062 | 1.6 K to 4.1 K (+160.05 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Option Exercise | M | 2.03 | 2,500 | 5,075 | 204,968 | |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Sell | S | 26.00 | 2,500 | 65,000 | 1,562 | 4.1 K to 1.6 K (-61.55 %) |
| Jan 19 2021 | PCVX | Vaxcyte, Inc. | Wright-Mitchell Jane | General Counsel | Buy | M | 2.03 | 2,500 | 5,075 | 4,062 | 1.6 K to 4.1 K (+160.05 %) |
Page: 1